Molly Kulesz-Martin

Professor

  • 2781 Citations
  • 29 h-Index
1980 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Molly Kulesz-Martin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Keratinocytes Medicine & Life Sciences
Skin Medicine & Life Sciences
Carcinogenesis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinogens Medicine & Life Sciences
DNA Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1981 2020

Atlases
Neoplasms
Genome
Pharmaceutical Preparations
Heterografts
Therapeutics
Neoplasms
Molecular Targeted Therapy
Cellular Microenvironment
Phosphatidylinositol 3-Kinases
Carcinogenesis
Cultured Cells
Epithelial Cells
Proteins
Neoplasms

Research Output 1980 2019

  • 2781 Citations
  • 29 h-Index
  • 104 Article
  • 3 Chapter
  • 1 Conference contribution
  • 1 Short survey
2 Citations (Scopus)

Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains

Di Rienzo, M., Antonioli, M., Fusco, C., Liu, Y., Mari, M., Orhon, I., Refolo, G., Germani, F., Corazzari, M., Romagnoli, A., Ciccosanti, F., Mandriani, B., Pellico, M. T., De La Torre, R., Ding, H., Dentice, M., Neri, M., Ferlini, A., Reggiori, F., Kulesz-Martin, M. & 3 others, Piacentini, M., Merla, G. & Fimia, G. M., Jan 1 2019, In : Science Advances. 5, 5, eaau8857.

Research output: Contribution to journalArticle

Open Access
muscle cells
muscles
induction
activation
mutations

Natural product target network reveals potential for cancer combination therapies

Chamberlin, S. R., Blucher, A., Wu, G., Shinto, L., Choonoo, G., Kulesz-Martin, M. & McWeeney, S., Jan 1 2019, In : Frontiers in Pharmacology. 10, MAY, 557.

Research output: Contribution to journalArticle

Open Access
Biological Products
Neoplasms
Therapeutics
Drug Interactions
Pharmaceutical Preparations
8 Citations (Scopus)

Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy

Medler, T. R., Murugan, D., Horton, W., Kumar, S., Cotechini, T., Forsyth, A. M., Leyshock, P., Leitenberger, J. J., Kulesz-Martin, M., Margolin, A., Werb, Z. & Coussens, L., Oct 8 2018, In : Cancer Cell. 34, 4, p. 561-578.e6

Research output: Contribution to journalArticle

Complement C5a
Carcinogenesis
Macrophages
T-Lymphocytes
Drug Therapy
1 Citation (Scopus)

Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models

Ouyang, X., Barling, A., Lesch, A., Tyner, J., Choonoo, G., Zheng, C., Jeng, S., West, T. M., Clayburgh, D., Courtneidge, S., McWeeney, S. & Kulesz-Martin, M., Oct 3 2018, In : Cancer Biology and Therapy. 19, 10, p. 921-933 13 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Small Interfering RNA
anaplastic lymphoma kinase
Carcinoma, squamous cell of head and neck
Neoplasms

Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment

Tolar, J., Bauer, J. W., Kaplan, D. H., Leachman, S., McGrath, J. A., Paller, A. S., Griffith-Bauer, K. A., Stemwedel, C. E. & Kulesz-Martin, M., Jun 1 2018, In : Journal of Investigative Dermatology. 138, 6, p. 1243-1248 6 p.

Research output: Contribution to journalArticle

Precision Medicine
Dermatology
Genomics
Skin Diseases
Biomedical Research